Video

Dr. Gomella on the Challenges of Genetic Testing in Prostate Cancer

Leonard G. Gomella, MD, discusses the challenges of genetic testing in prostate cancer.

Leonard G. Gomella, MD, professor, chair, Department of Urology, director, Sidney Kimmel Cancer Center Network, Thomas Jefferson University Hospital, discusses the challenges of genetic testing in prostate cancer.

Although the role genetic testing is expanding in prostate cancer and across cancer types, there is much to be discovered. Moreover, the genetic components of the disease are not as well established in prostate cancer as they are in other tumor types such as breast cancer.

At the 2019 Prostate Cancer Consensus Conference, experts in the field discussed the growing need for genetic testing and genetic counselors in prostate cancer. Moreover, experts provided insight on the patient populations who should undergo genetic testing verses those who do not need formal testing.

Related Videos
James J. Harding, MD, associate attending physician, Memorial Sloan Kettering Cancer Center
J. Bradley Elder, MD
Rimas V. Lukas, MD
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Shubham Pant, MD, MBBS
Kevin Kalinsky, MD, MS, professor, Department of Hematology and Medical Oncology, director, Division of Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine; Louisa and Rand Glenn Family Chair in Breast Cancer Research, director, Glenn Family Breast Center, director, Breast Medical Oncology, Winship Cancer Institute of Emory University
Brett L. Ecker, MD
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center